Clinical Trial Update: Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants [Phase 1]

View source ↗

Summary

This is a completed Phase 1 clinical trial evaluating PENNVAX-B (Gag, Pol, Env) delivered by electroporation in adults infected with HIV-1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PENNVAX-B (PENNVAX-B DNA vaccine)

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: HIV-1 Infection, HIV Infections | Phase 1 | Status: COMPLETED